The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 20, 2021
Filed:
Mar. 20, 2020
Applicant:
Sdf Biopharma Inc., Rancho Santa Fe, CA (US);
Inventors:
Gerald F. Swiss, Rancho Santa Fe, CA (US);
David Kiewlich, Alameda, CA (US);
Assignee:
SDF BioPharma Inc., Rancho Santa Fe, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/85 (2006.01); C12N 5/071 (2010.01); A61P 3/10 (2006.01); A61K 35/17 (2015.01); C12N 5/0783 (2010.01); C12N 5/0781 (2010.01); A61K 35/39 (2015.01); C07K 14/52 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0676 (2013.01); A61K 35/17 (2013.01); A61K 35/39 (2013.01); A61P 3/10 (2018.01); C07K 14/522 (2013.01); C12N 5/0635 (2013.01); C12N 5/0638 (2013.01); C12N 5/0646 (2013.01); C12N 5/0686 (2013.01); C12N 2501/998 (2013.01); C12N 2502/11 (2013.01); C12N 2502/99 (2013.01); C12N 2510/00 (2013.01);
Abstract
Described herein are human transgenic beta cells expressing fugetactic levels of CXCL12 to a subject in need thereof. Also described herein are beta cells comprising a transgene comprising a nucleic acid sequence encoding CXCL12.